Welcome to the American Family Physician Podcast for the February 1st, 2016 issue.

I'm Steve.

I'm Kelsey.

I'm Megan.

I'm Jake.

We are residents and faculty, mostly residents of the University of Arizona College of Medicine, Phoenix Family Medicine residency.

This week, we're going to talk about organ transplant,

cyclobenzaprine, foot fractures, quinine, electronic cigarettes, steroids for pneumonia,

and frequently asked questions about family medicine. The opinions expressed in the podcast are

our own and do not represent the opinions of the American Academy of Family Physicians, the editor of American Family Physician or Banner Health.

Do not use this podcast for medical advice. Instead, see your own family doctor for medical care.

We're on a mission delivering the best from American family physician. On a mission. Delivering the best from American Family Physician on a mission delivering the best from American Family Physician.

Let's start with one of our feature articles this month, primary care of the solid organ transplant recipient from Dr.

Samino and Snyder out of Bethesda, Maryland, and Bremerton, Washington.

Transplant patients are living longer, and primary care physicians are seeing more post-transplant

patients as a result. It's important to review special considerations in providing primary

care to these patients. So important to note, immunosuppressive therapy accounts for more than 50% of transplant

related deaths. So let's review the different types of immunosuppressive categories. First, there's

the calcium neuron inhibitors, things like tachrylamis, which is also called prograph. There's also

the mammalian target of rapamycin inhibitors like serolimus, and then there's the purine synthesis

inhibitors like mycophenolate or cell set. The concentration of these medications are easily

affected by other medicines that transplant patients are often on. Table one gives a great review of

...